Trials / Completed
CompletedNCT03183739
Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects
ASP8062 Phase 1 Study - A Placebo-controlled, Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Male and Female Subjects -
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and tolerability and evaluate pharmacokinetics of single and multiple ascending oral doses of ASP8062 in nonelderly Japanese male and female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP8062 | ASP8062 will be administered orally. |
| DRUG | Placebo | Placebo will be administered orally. |
Timeline
- Start date
- 2017-06-20
- Primary completion
- 2017-10-06
- Completion
- 2017-10-06
- First posted
- 2017-06-12
- Last updated
- 2024-10-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03183739. Inclusion in this directory is not an endorsement.